L-Glutamine
EmergingMost abundant free amino acid in plasma and skeletal muscle; conditionally essential during catabolic stress. | Supplement · Powder
Aliases (5)
▸ Mixing & scoop math Powder
- • Mix into 8-16 oz cold water (or sports drink / protein shake). Most powders dissolve in < 30 sec with a brisk stir.
- • If using a shaker, add liquid first, then powder, then shake — minimizes foam and clumps.
- • Hot water is fine for most amino acids and creatine; avoid for heat-sensitive compounds (NAC degrades above ~60 °C).
- • Drink within 5-10 min of mixing — most powders are stable in solution but taste degrades.
▸ Overview TL;DR
Most abundant free amino acid in plasma and skeletal muscle; conditionally essential during catabolic stress. ICU/burn/sepsis evidence is robust and life-saving; healthy-adult athletic recovery and cognitive evidence is weak. For Dylan: OPTIONAL-ADD at 5g/day as gut + immune insurance during high MMA training load — useful adjunct, not a cognitive primary, not a transformative supplement.
▸ Mechanism of action
Glutamine is a non-essential alpha-amino acid that becomes conditionally essential under physiological stress (trauma, sepsis, burns, severe overtraining, prolonged catabolism). Endogenous synthesis from glutamate + ammonia via glutamine synthetase (GS) is normally adequate, but demand outstrips supply in catabolic states. It is the most abundant free amino acid in human plasma (~500-750 µmol/L) and skeletal muscle (~20 mmol/kg wet weight, accounting for 50-60% of intramuscular free amino acid pool).
Distinct mechanisms relevant to supplementation:
Primary fuel for rapidly dividing cells. Enterocytes (gut lining), lymphocytes, macrophages, and neutrophils preferentially oxidize glutamine over glucose. The gut alone consumes ~30% of dietary glutamine first-pass; almost nothing reaches the systemic circulation from oral supplementation in healthy adults — a significant pharmacokinetic limitation. Splanchnic extraction is the dominant fate.
Glutamate / GABA precursor. Glutamine crosses the blood-brain barrier via SLC1A5 (ASCT2) and SLC7A11, and is converted intracellularly to glutamate by glutaminase (GLS / GLS2). Glutamate is the primary excitatory neurotransmitter and the precursor to GABA via glutamic acid decarboxylase (GAD). The glutamine-glutamate-GABA cycle is the dominant CNS nitrogen flux. Despite the mechanistic story, oral supplementation produces minimal CNS glutamate elevation in healthy humans because of first-pass splanchnic extraction.
Ammonia scavenger. Glutamine synthetase combines glutamate + NH3 + ATP to form glutamine, providing a non-toxic nitrogen carrier between tissues. Skeletal muscle and brain export ammonia as glutamine; liver and kidney use it for urea production or renal acid-base balance. After exhaustive exercise, plasma ammonia rises 5-10x; glutamine supplementation modestly accelerates clearance. This is the main mechanistic basis for the "post-exercise cognitive fog" claim.
Heat shock protein (HSP70) induction. Glutamine increases HSP70 expression in stressed cells, contributing to its protective effect in ICU/sepsis populations. HSP70 stabilizes proteins, prevents apoptosis, and reduces inflammatory signaling. This mechanism likely underlies the mortality benefit in critical illness.
Glutathione (GSH) substrate. Glutamine donates carbon to glutamate, which combines with cysteine + glycine to form GSH. In glutamine-restricted cells, GSH synthesis falls and oxidative stress rises. Practically, NAC (cysteine donor) is the rate-limiting input; glutamine is rarely limiting for GSH in healthy adults.
Anaplerotic feed to the TCA cycle. Glutamine-derived alpha-ketoglutarate replenishes TCA intermediates. In catabolic states or rapidly proliferating cells (cancer, immune cells), this is metabolically critical. Cancer cells are notably glutamine-addicted — relevant for risk discussion below.
Nitrogen shuttle. Glutamine is the dominant inter-organ nitrogen carrier in humans. Muscle releases glutamine; gut, kidney, and liver consume it. This is why plasma glutamine drops in prolonged catabolism — muscle protein breakdown is the source.
▸ Pharmacokinetics No data
▸Quality indicators4 checks
▸ What to expect Generic
- 1First doseFor stim-class powders: acute effect within 30-60 min.
- 2Week 1-2For volumizers (creatine, betaine): muscle fullness builds.
- 3Week 2-4Performance gains plateau into a new baseline.
- 4OngoingMaintenance dose continuous; cycle off only if specific indication.
▸ Side effects + safety
- Common (>10% users): None reliably. Most users report nothing.
- Less common (1-10%): Mild GI discomfort, bloating, gas at single doses >10g, especially on empty stomach. Resolves with smaller doses or food.
- Rare-serious (<1%):
- Theoretical cancer risk. Cancer cells are notably glutamine-addicted (Warburg metabolism extends to glutamine consumption — "glutaminolysis"). Glutamine supplementation in active cancer is contraindicated by some oncologists and explicitly endorsed by others (mucositis benefit). Healthy adults: theoretical concern only, no human evidence of increased cancer incidence with supplementation. Worth filing.
- Hepatic encephalopathy / cirrhosis. Glutamine is converted to glutamate + ammonia in the gut and brain; in cirrhotic patients with impaired urea cycle, supplementation could theoretically worsen ammonia load. Avoid in liver disease.
- Bipolar / seizure disorders (theoretical). Glutamate is excitatory; glutamine raises CNS glutamate marginally. Theoretical destabilization risk — not documented in healthy adults but worth flagging for those populations.
- REDOXS 2013 mortality signal. High-dose parenteral glutamine in multi-organ-failure ICU patients increased mortality. This is not relevant to oral supplementation in healthy adults but explains why some clinicians are cautious about glutamine megadosing.
- Specific watch periods: None standard. Bloodwork at 8-12 weeks is reasonable but not strictly required at 5g/day.
Upper safe intake:
- 2008 Shao & Hathcock risk assessment (same source as taurine): Observed Safe Level 14 g/day for healthy adults; doses up to 40 g/day tolerated in research without specific harm signal.
- Highest tested human chronic dose: 40 g/day for several weeks (well-tolerated).
- Practical ceiling: 10 g for daily-driver use; 20-30 g during defined clinical windows (mucositis, ICU) only.
▸Interactions9 compounds
- n-acetyl-cysteine (NAC):SynergisticBoth contribute to glutathione synthesis (NAC = cysteine donor; glutamine = glutamate donor). NAC is rate-limiting; glutamine helps marginally. Reasonable mi…
- glycine:SynergisticBoth are gut barrier supportive amino acids. Glycine has additional sleep, collagen, and methylation roles. Stack-safe; common in "gut healing" protocols.
- taurine:SynergisticBoth osmolyte / cell-volume / mitochondrial-support amino acids. Both daily-safe. Stack-safe.
- alcar:SynergisticMitochondrial energy support; ALCAR provides acetyl + carnitine for fatty-acid oxidation; glutamine provides anaplerotic alpha-ketoglutarate. Theoretical syn…
- Probiotics, zinc carnosine, deglycyrrhizinated licorice:SynergisticStandard "gut healing" stack. Glutamine is the foundational amino acid in this protocol; the others are complementary.
- EAA / BCAA:SynergisticGlutamine is technically not in BCAA (leucine, isoleucine, valine), but is included in some "fermented EAA" formulas. No antagonism. Stack-safe.
- Cancer chemotherapy (without oncologist guidance):AvoidWhile glutamine is used clinically for chemo-mucositis, the simultaneous concern about feeding cancer cells means oncologist-led dosing only.
- Lithium, MAOI, high-dose stimulants:AvoidNo documented direct interaction, but in seizure-prone or psychiatrically unstable individuals the glutamate-precursor mechanism is a theoretical concern. Co…
- Active hepatic encephalopathy / advanced cirrhosis:AvoidAvoid — ammonia load.
▸References18 sources
Cruzat et al. 2018 — Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation (Nutrients)
2018comprehensive review of mechanism, immune function, and clinical use
Castell et al. 1996 — Does glutamine have a role in reducing infections in athletes? (Eur J Appl Physiol)
1996original athlete-immunity evidence
Castell & Newsholme 1997 — The effects of oral glutamine supplementation on athletes after prolonged, exhaustive exercise (Nutrition)
1997followup on URTI reduction
Bowtell et al. 1999 — Effect of oral glutamine on whole body carbohydrate storage during recovery from exhaustive exercise (J Appl Physiol)
1999glycogen resynthesis evidence
Coqueiro et al. 2019 — Glutamine as an anti-fatigue amino acid in sports nutrition (Nutrients)
2019modern athletic-recovery review
Cordova-Martinez et al. 2021 — Effect of glutamine supplementation on muscular damage biomarkers (Nutrients)
2021recent meta-analysis on muscle damage markers
Heyland et al. 2013 — REDOXS trial — A randomized trial of glutamine and antioxidants in critically ill patients (NEJM)
2013the parenteral mortality signal
van Zanten et al. 2014 — Enteral Glutamine Supplementation in Critically Ill Patients (Crit Care)
2014enteral vs parenteral distinction
Tao et al. 2014 — Glutamine for chemotherapy-induced oral mucositis meta-analysis
2014chemo-mucositis evidence
Achamrah et al. 2017 — Glutamine and the regulation of intestinal permeability (Curr Opin Clin Nutr Metab Care)
2017gut permeability mechanism review
Wang et al. 2015 — Glutamine and intestinal barrier function (Amino Acids)
2015gut barrier review
Shao & Hathcock 2008 — Risk assessment for taurine, glutamine, arginine
2008safety / upper-intake review (covers glutamine)
Cochrane 2017 — Glutamine supplementation for critically ill adults
2017Cochrane systematic review
Newsholme 2001 — Why is L-glutamine metabolism important to cells of the immune system? (J Nutr)
2001foundational immune metabolism paper
Glutamine — Examine.com
practical reference with summary of clinical evidence
BulkSupplements L-Glutamine powder
Dylan's likely vendor path
NOW Foods L-Glutamine
alternate vendor
Nootropics Depot L-Glutamine
third-party tested vendor option